No Data
Vertex Pharmaceuticals Raise FY Revenue Outlook Boosted, as Q3 Results Beat
Express News | Shares of Vertex Pharma Rise 1.7% in Extended Trade Following Quarterly Report
Vertex Pharmaceuticals Non-GAAP EPS of $4.38 Beats by $0.25, Revenue of $2.77B Beats by $80M
Express News | Vertex Pharmaceuticals Outlook FY Product Revenue USD 10,800-10,900 Million
Express News | Vertex Pharmaceuticals Q3 Revenue USD 2,771.9 Million Vs. IBES Estimate USD 2,724 Million
Vertex Reports Third Quarter 2024 Financial Results